Page last updated: 2024-11-05

calcium chromate(vi)

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

calcium chromate(VI): RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID26264
MeSH IDM0104529

Synonyms (30)

Synonym
hsdb 248
nsc 176337
chromic acid, calcium salt
calcium chromate(vi)
ccris 156
chromic acid h2cro4, calcium salt
rcra waste number u032
rcra waste no. u032
sintered calcium chromate
einecs 237-366-8
calcium chrome yellow
calcium chromate
gelbin
calcium monochromate
yellow ultramarine
13765-19-0
53568-70-0
unii-j1fgh4zj4m
j1fgh4zj4m ,
12205-18-4
chromate (cro4(3-)), calcium (2:3), (t-4)-
AKOS015914152
calcium chromate [hsdb]
calcium chromate(vi) [mi]
ci 77223
DTXSID0024717
calcium chromate, aldrichcpr
mfcd00049403
Q905723
calcium;dioxido(dioxo)chromium

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" These results demonstrate differences in the sensitivity of human, hamster, and mouse cells to CaCrO4 and suggest that the repair-resistant DNA-protein cross-link may be important in mediating the long term toxic and carcinogenic effects of CaCrO4."( Comparison of DNA lesions and cytotoxicity induced by calcium chromate in human, mouse, and hamster cell lines.
Costa, M; Sugiyama, M; Wang, XW, 1986
)
0.27
" In vivo exposure of the macrophage to either chromium compound showed no toxic effects at a 2-micrograms dose."( Toxicity of hexavalent chromium to the alveolar macrophage in vivo and in vitro.
Galvin, JB; Oberg, SG, 1984
)
0.27

Dosage Studied

ExcerptRelevanceReference
" Soluble hexavalent CaCrO4, administered in either acute (5-h) or subacute (24-h) dosing regimens, induced dose-dependent cytotoxicity and mutation to 6-thioguanine resistance in Chinese hamster ovary cells but no mutation to ouabain resistance or focus formation in transformation assays, although the acute treatment induced a high frequency of conversion of 10T1/2 cells to adipocytes."( Transformation of C3H/10T1/2 mouse embryo cells to focus formation and anchorage independence by insoluble lead chromate but not soluble calcium chromate: relationship to mutagenesis and internalization of lead chromate particles.
Banh, D; Landolph, JR; Patierno, SR, 1988
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (64.71)18.7374
1990's2 (11.76)18.2507
2000's3 (17.65)29.6817
2010's1 (5.88)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.26

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.26 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index4.26 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.26)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]